(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2(Date:8/18/2008)...ewswire-USNewswire/ -- Boston University and Aubre...r for Human Genetics, Inc.,("CHG") and Director of...y,announced that CHG will no longer offer testing...agnostics, Inc., These patented tests include tes...1555G or Connexin 26 mutations, developmental diso...
(Date:8/18/2008)...al Trials Phase of Test Development Program, ORAN...-- Beckman,Coulter, Inc. (NYSE: BEC ) announced t...S. royalty obligation to Nephromics LLC, a Chestnu...lth. The license is for tests,related to the detec...ia, a,leading cause of maternal death. In addition...
(Date:8/18/2008)...18 /- Micromet, Inc.,(Nasda... novel, proprietary,antibodies for the treatment o...ll host a webcast and conference call this morning...ime (4:00 p.m. Central European,Time) to discuss t...urnal,SCIENCE on August 15, 2008., To access the ...
(Date:8/14/2008)...- AstraZeneca (NYSE: AZN )...h the National Cancer,Centre Singapore (NCCS) and ...anti-cancer compounds. The collaboration, which is...that was signed today, aims to further,build Astra... ultimately,speed up access to new medicines of po...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 1Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 2Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 3National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 1National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 1Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 1First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 2First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 4...zation with a Bavituximab Equivalent and Irradiate...From 0% in Controls in a,Preclinical Model of Brai...18, 2007,/PRNewswire-FirstCall/ -- Peregrine Pharm...cal company developing targeted,monoclonal antibod...rus (HCV) infection, today announced preclinical s...
..., Wash., April 18, 2007 /PRNewswire-FirstCall/ -- ...Falla, Ph.D, Chief,Scientific Officer, will presen...ll molecule peptide (lipohexapeptide) technology,a... will take place,at the Boston Convention & Ex... 9th. Dr. Falla,s presentation is scheduled for,We...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4Latex agglutination inhibition slide test for the qualitative detection of hCG in urine.
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum.
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood.
Color-enhanced slide agglutination test for the rapid qualitative and semi-quantitative detection of antistreptolysin O.
Medicine Products: